Relationship between metabolism and biomass of medically important zygomycetes

References

• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236–301
   PubMed Web of Science ®Google Scholar
• Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634–653
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005; 191: 1350–1360
   PubMed Web of Science ®Google Scholar
• Pagano L, Offidani M, Fianchi L, et al. Mucormycosis in hematologic patients. Haematologica 2004; 89: 207–214
   PubMed Web of Science ®Google Scholar
• Meshulam T, Levitz SM, Christin L, Diamond RD. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). J Infect Dis 1995; 172: 1153–1156
   PubMed Web of Science ®Google Scholar
• Meletiadis J, Mouton JW, Meis JF, et al. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 2001; 39: 4256–4263
   PubMed Web of Science ®Google Scholar
• Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998; 36: 1450–1452
   PubMed Web of Science ®Google Scholar
• Hawser SP, Jessup C, Vitullo J, Ghannoum MA. Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tet razolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class compounds. J Clin Microbiol 2001; 39: 2738–2741
   PubMed Web of Science ®Google Scholar
• Lionakis MS, Lewis RE, Samonis G, Kontoyiannis DP. Pentamidine is active in vitro against Fusarium species. Antimicrob Agents Chemother 2003; 47: 3252–3259
   PubMed Web of Science ®Google Scholar
• Lewis RE, Wiederhold NP, Klepser ME. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Antimicrob Agents Chemother 2005; 49: 945–951
   PubMed Web of Science ®Google Scholar
• Yekutiel A, Shalit I, Shadkchan Y, Osherov N. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 2004; 48: 3279–3283
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Balkis M, Chandra J, Mukherjee PK, Ghannoum MA. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Microbiol 2003; 41: 506–508
   PubMed Web of Science ®Google Scholar
• Rinaldi MG. Use of potato flakes agar in clinical mycology. J Clin Microbiol 1982; 15: 1159–1160
   PubMed Web of Science ®Google Scholar
• Pincus DH, Salkin IF, Hurd NJ, Levy IL, Kemna MA. Modification of potassium nitrate assimilation test for identification of clinically important yeasts. J Clin Microbiol 1988; 26: 366–368
   PubMedGoogle Scholar
• Shipper MAA, Stalpers JA. Zygomycetes. The Order Mucorales. Pathogenic Fungi in Humans and Animals, DH Howard. Marcel Dekker, Inc, New York 2003; 67–125
   Google Scholar
• White TJ, Bruns TD, Lee SB, Taylor JW. Amplification and sequencing of fungal ribosomal RNA genes for phylogenetics. PCR – Protocols and Applications – A Laboratory Manual, N Innis, D Gelfand, J Sninsky, TC White. Academic Press, New York 1990; 315–322
   Google Scholar
• Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216–1223
   PubMed Web of Science ®Google Scholar
• Peterson SW, Kurtzman CP. Phylogenetic relationships among species of the genus Issatchenkia Kudriavzev. Antonie Van Leeuwenhoek 1990; 58: 235–240
   PubMed Web of Science ®Google Scholar
• Burnham KP AD. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach2nd edn. Springer-Verlag, New York 2002
   Google Scholar
• Meletiadis J, Meis JF, Mouton JW, Verweij PE. Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol 2001; 39: 478–484
   PubMed Web of Science ®Google Scholar
• Meletiadis J, te Dorsthorst DT, Verweij PE. Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi. J Clin Microbiol 2003; 41: 4718–4725
   Google Scholar
• Bai Z, Harvey LM, McNeil B. Physiological responses of chemostat cultures of Aspergillus niger (B1-D) to simulated and actual oxidative stress. Biotechnol Bioeng 2003; 82: 691–701
   PubMed Web of Science ®Google Scholar
• Bradner JR, Nevalainen KM. Metabolic activity in filamentous fungi can be analysed by flow cytometry. J Microbiol Methods 2003; 54: 193–201
   PubMedGoogle Scholar
• Espinel-Ingroff A, Bartlett M, Bowden R, et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol 1997; 35: 139–143
   PubMed Web of Science ®Google Scholar
• Meletiadis J, Meis JF, Mouton JW, Donnelly JP, Verweij PE. Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol 2000; 38: 2949–2954
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Simitsopoulou M, Roilides E, et al. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis 2005; 191: 1180–1187
   PubMed Web of Science ®Google Scholar